nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetazolamide—CA9—kidney cancer	0.318	0.527	CbGaD
Acetazolamide—CA2—kidney cancer	0.286	0.473	CbGaD
Acetazolamide—AQP1—collecting duct of renal tubule—kidney cancer	0.0251	0.292	CbGeAlD
Acetazolamide—CYP3A4—Everolimus—kidney cancer	0.0193	0.293	CbGbCtD
Acetazolamide—CYP3A4—Temsirolimus—kidney cancer	0.013	0.198	CbGbCtD
Acetazolamide—AQP1—nephron—kidney cancer	0.0112	0.13	CbGeAlD
Acetazolamide—AQP1—urine—kidney cancer	0.00897	0.104	CbGeAlD
Acetazolamide—CYP3A4—Pazopanib—kidney cancer	0.00684	0.104	CbGbCtD
Acetazolamide—CA2—collecting duct of renal tubule—kidney cancer	0.0067	0.0779	CbGeAlD
Acetazolamide—CYP3A4—Erlotinib—kidney cancer	0.00488	0.0741	CbGbCtD
Acetazolamide—CYP3A4—Paclitaxel—kidney cancer	0.00447	0.0678	CbGbCtD
Acetazolamide—CYP3A4—Sorafenib—kidney cancer	0.00397	0.0603	CbGbCtD
Acetazolamide—CYP3A4—Vinblastine—kidney cancer	0.00392	0.0595	CbGbCtD
Acetazolamide—CYP3A4—Vincristine—kidney cancer	0.00385	0.0585	CbGbCtD
Acetazolamide—CYP3A4—Sunitinib—kidney cancer	0.00322	0.0488	CbGbCtD
Acetazolamide—Methazolamide—CA9—kidney cancer	0.00279	0.526	CrCbGaD
Acetazolamide—Methazolamide—CA2—kidney cancer	0.00251	0.473	CrCbGaD
Acetazolamide—AQP1—nephron tubule—kidney cancer	0.00242	0.0281	CbGeAlD
Acetazolamide—CYP3A4—Doxorubicin—kidney cancer	0.00241	0.0366	CbGbCtD
Acetazolamide—AQP1—renal system—kidney cancer	0.0022	0.0255	CbGeAlD
Acetazolamide—AQP1—kidney—kidney cancer	0.00212	0.0247	CbGeAlD
Acetazolamide—AQP1—cortex of kidney—kidney cancer	0.00207	0.024	CbGeAlD
Acetazolamide—AQP1—cardiac atrium—kidney cancer	0.00197	0.0229	CbGeAlD
Acetazolamide—CA7—renal system—kidney cancer	0.00176	0.0204	CbGeAlD
Acetazolamide—CA7—kidney—kidney cancer	0.0017	0.0197	CbGeAlD
Acetazolamide—CYP3A4—urine—kidney cancer	0.00154	0.0179	CbGeAlD
Acetazolamide—CA3—cardiac atrium—kidney cancer	0.00144	0.0168	CbGeAlD
Acetazolamide—SLC22A6—nephron tubule—kidney cancer	0.0014	0.0163	CbGeAlD
Acetazolamide—CA14—cardiac atrium—kidney cancer	0.00131	0.0152	CbGeAlD
Acetazolamide—SLC22A6—cortex of kidney—kidney cancer	0.0012	0.0139	CbGeAlD
Acetazolamide—CA12—renal system—kidney cancer	0.00114	0.0133	CbGeAlD
Acetazolamide—CA12—kidney—kidney cancer	0.0011	0.0128	CbGeAlD
Acetazolamide—CA5B—gonad—kidney cancer	0.000917	0.0107	CbGeAlD
Acetazolamide—CA5B—cardiac atrium—kidney cancer	0.000916	0.0106	CbGeAlD
Acetazolamide—CA1—renal system—kidney cancer	0.000903	0.0105	CbGeAlD
Acetazolamide—CA1—kidney—kidney cancer	0.000873	0.0101	CbGeAlD
Acetazolamide—CA4—nephron tubule—kidney cancer	0.000777	0.00903	CbGeAlD
Acetazolamide—CA4—renal system—kidney cancer	0.000706	0.00821	CbGeAlD
Acetazolamide—CA4—kidney—kidney cancer	0.000683	0.00793	CbGeAlD
Acetazolamide—CA4—cortex of kidney—kidney cancer	0.000665	0.00773	CbGeAlD
Acetazolamide—CA2—nephron tubule—kidney cancer	0.000644	0.00748	CbGeAlD
Acetazolamide—CA4—cardiac atrium—kidney cancer	0.000632	0.00735	CbGeAlD
Acetazolamide—CA2—renal system—kidney cancer	0.000585	0.0068	CbGeAlD
Acetazolamide—CA2—kidney—kidney cancer	0.000566	0.00658	CbGeAlD
Acetazolamide—CA2—cortex of kidney—kidney cancer	0.000551	0.00641	CbGeAlD
Acetazolamide—CA2—cardiac atrium—kidney cancer	0.000524	0.00609	CbGeAlD
Acetazolamide—CYP3A4—renal system—kidney cancer	0.000378	0.00439	CbGeAlD
Acetazolamide—CYP3A4—kidney—kidney cancer	0.000365	0.00424	CbGeAlD
Acetazolamide—Shock—Everolimus—kidney cancer	0.000294	0.00253	CcSEcCtD
Acetazolamide—Thrombocytopenia—Vinblastine—kidney cancer	0.000294	0.00253	CcSEcCtD
Acetazolamide—Agranulocytosis—Gemcitabine—kidney cancer	0.000293	0.00252	CcSEcCtD
Acetazolamide—Thrombocytopenia—Everolimus—kidney cancer	0.000292	0.00252	CcSEcCtD
Acetazolamide—Asthenia—Temsirolimus—kidney cancer	0.000288	0.00248	CcSEcCtD
Acetazolamide—Leukopenia—Sorafenib—kidney cancer	0.000284	0.00245	CcSEcCtD
Acetazolamide—Shock—Erlotinib—kidney cancer	0.000284	0.00244	CcSEcCtD
Acetazolamide—Jaundice cholestatic—Doxorubicin—kidney cancer	0.000283	0.00243	CcSEcCtD
Acetazolamide—Thrombocytopenia—Erlotinib—kidney cancer	0.000282	0.00243	CcSEcCtD
Acetazolamide—Hyponatraemia—Capecitabine—kidney cancer	0.000281	0.00242	CcSEcCtD
Acetazolamide—Diarrhoea—Temsirolimus—kidney cancer	0.000275	0.00237	CcSEcCtD
Acetazolamide—Leukopenia—Sunitinib—kidney cancer	0.000274	0.00236	CcSEcCtD
Acetazolamide—Asthenia—Pazopanib—kidney cancer	0.000271	0.00234	CcSEcCtD
Acetazolamide—Paraesthesia—Vinblastine—kidney cancer	0.000269	0.00232	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Paclitaxel—kidney cancer	0.000269	0.00232	CcSEcCtD
Acetazolamide—Ill-defined disorder—Dactinomycin—kidney cancer	0.000268	0.00231	CcSEcCtD
Acetazolamide—Paraesthesia—Everolimus—kidney cancer	0.000268	0.00231	CcSEcCtD
Acetazolamide—Irritability—Capecitabine—kidney cancer	0.000267	0.0023	CcSEcCtD
Acetazolamide—Erythema multiforme—Gemcitabine—kidney cancer	0.000266	0.00229	CcSEcCtD
Acetazolamide—Somnolence—Everolimus—kidney cancer	0.000266	0.00229	CcSEcCtD
Acetazolamide—Dizziness—Temsirolimus—kidney cancer	0.000266	0.00229	CcSEcCtD
Acetazolamide—Convulsion—Sunitinib—kidney cancer	0.000265	0.00228	CcSEcCtD
Acetazolamide—Ataxia—Capecitabine—kidney cancer	0.000263	0.00227	CcSEcCtD
Acetazolamide—Dyspepsia—Everolimus—kidney cancer	0.000263	0.00226	CcSEcCtD
Acetazolamide—Malaise—Dactinomycin—kidney cancer	0.000261	0.00225	CcSEcCtD
Acetazolamide—Decreased appetite—Vinblastine—kidney cancer	0.000261	0.00224	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Paclitaxel—kidney cancer	0.000261	0.00224	CcSEcCtD
Acetazolamide—Decreased appetite—Everolimus—kidney cancer	0.00026	0.00224	CcSEcCtD
Acetazolamide—Anaphylactic shock—Sorafenib—kidney cancer	0.000259	0.00223	CcSEcCtD
Acetazolamide—Leukopenia—Dactinomycin—kidney cancer	0.000259	0.00223	CcSEcCtD
Acetazolamide—Diarrhoea—Pazopanib—kidney cancer	0.000259	0.00223	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Everolimus—kidney cancer	0.000258	0.00222	CcSEcCtD
Acetazolamide—Fatigue—Everolimus—kidney cancer	0.000258	0.00222	CcSEcCtD
Acetazolamide—Vomiting—Temsirolimus—kidney cancer	0.000255	0.0022	CcSEcCtD
Acetazolamide—Shock—Sorafenib—kidney cancer	0.000255	0.0022	CcSEcCtD
Acetazolamide—Hypokalaemia—Capecitabine—kidney cancer	0.000255	0.00219	CcSEcCtD
Acetazolamide—Thrombocytopenia—Sorafenib—kidney cancer	0.000254	0.00219	CcSEcCtD
Acetazolamide—Dyspepsia—Erlotinib—kidney cancer	0.000254	0.00218	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Capecitabine—kidney cancer	0.000252	0.00217	CcSEcCtD
Acetazolamide—Headache—Temsirolimus—kidney cancer	0.000252	0.00217	CcSEcCtD
Acetazolamide—Haematuria—Paclitaxel—kidney cancer	0.000251	0.00216	CcSEcCtD
Acetazolamide—Decreased appetite—Erlotinib—kidney cancer	0.000251	0.00216	CcSEcCtD
Acetazolamide—Dizziness—Pazopanib—kidney cancer	0.00025	0.00215	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000249	0.00214	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Paclitaxel—kidney cancer	0.000249	0.00214	CcSEcCtD
Acetazolamide—Fatigue—Erlotinib—kidney cancer	0.000248	0.00214	CcSEcCtD
Acetazolamide—Feeling abnormal—Vinblastine—kidney cancer	0.000247	0.00213	CcSEcCtD
Acetazolamide—Feeling abnormal—Everolimus—kidney cancer	0.000246	0.00212	CcSEcCtD
Acetazolamide—Shock—Sunitinib—kidney cancer	0.000245	0.00211	CcSEcCtD
Acetazolamide—Thrombocytopenia—Sunitinib—kidney cancer	0.000244	0.0021	CcSEcCtD
Acetazolamide—Discomfort—Dactinomycin—kidney cancer	0.000243	0.0021	CcSEcCtD
Acetazolamide—Melaena—Doxorubicin—kidney cancer	0.000243	0.00209	CcSEcCtD
Acetazolamide—Vomiting—Pazopanib—kidney cancer	0.000241	0.00207	CcSEcCtD
Acetazolamide—Nausea—Temsirolimus—kidney cancer	0.000239	0.00205	CcSEcCtD
Acetazolamide—Agitation—Vincristine—kidney cancer	0.000238	0.00205	CcSEcCtD
Acetazolamide—Headache—Pazopanib—kidney cancer	0.000237	0.00204	CcSEcCtD
Acetazolamide—Body temperature increased—Everolimus—kidney cancer	0.000236	0.00203	CcSEcCtD
Acetazolamide—Hypoaesthesia—Paclitaxel—kidney cancer	0.000235	0.00202	CcSEcCtD
Acetazolamide—Aplastic anaemia—Doxorubicin—kidney cancer	0.000233	0.00201	CcSEcCtD
Acetazolamide—Leukopenia—Vincristine—kidney cancer	0.000231	0.00199	CcSEcCtD
Acetazolamide—Thrombocytopenia—Dactinomycin—kidney cancer	0.000231	0.00199	CcSEcCtD
Acetazolamide—Dyspepsia—Sorafenib—kidney cancer	0.000228	0.00196	CcSEcCtD
Acetazolamide—Body temperature increased—Erlotinib—kidney cancer	0.000228	0.00196	CcSEcCtD
Acetazolamide—Ill-defined disorder—Gemcitabine—kidney cancer	0.000228	0.00196	CcSEcCtD
Acetazolamide—Decreased appetite—Sorafenib—kidney cancer	0.000225	0.00194	CcSEcCtD
Acetazolamide—Nausea—Pazopanib—kidney cancer	0.000225	0.00193	CcSEcCtD
Acetazolamide—Paraesthesia—Sunitinib—kidney cancer	0.000224	0.00193	CcSEcCtD
Acetazolamide—Convulsion—Vincristine—kidney cancer	0.000224	0.00193	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000224	0.00193	CcSEcCtD
Acetazolamide—Fatigue—Sorafenib—kidney cancer	0.000224	0.00192	CcSEcCtD
Acetazolamide—Erythema multiforme—Paclitaxel—kidney cancer	0.000223	0.00192	CcSEcCtD
Acetazolamide—Malaise—Gemcitabine—kidney cancer	0.000221	0.0019	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Capecitabine—kidney cancer	0.000221	0.0019	CcSEcCtD
Acetazolamide—Tinnitus—Paclitaxel—kidney cancer	0.00022	0.00189	CcSEcCtD
Acetazolamide—Dyspepsia—Sunitinib—kidney cancer	0.00022	0.00189	CcSEcCtD
Acetazolamide—Leukopenia—Gemcitabine—kidney cancer	0.00022	0.00189	CcSEcCtD
Acetazolamide—Flushing—Paclitaxel—kidney cancer	0.000219	0.00188	CcSEcCtD
Acetazolamide—Decreased appetite—Sunitinib—kidney cancer	0.000217	0.00187	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000215	0.00185	CcSEcCtD
Acetazolamide—Asthenia—Vinblastine—kidney cancer	0.000215	0.00185	CcSEcCtD
Acetazolamide—Fatigue—Sunitinib—kidney cancer	0.000215	0.00185	CcSEcCtD
Acetazolamide—Asthenia—Everolimus—kidney cancer	0.000214	0.00184	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Capecitabine—kidney cancer	0.000214	0.00184	CcSEcCtD
Acetazolamide—Anaphylactic shock—Vincristine—kidney cancer	0.000211	0.00182	CcSEcCtD
Acetazolamide—Asthenia—Erlotinib—kidney cancer	0.000207	0.00178	CcSEcCtD
Acetazolamide—Thrombocytopenia—Vincristine—kidney cancer	0.000207	0.00178	CcSEcCtD
Acetazolamide—Hepatic function abnormal—Doxorubicin—kidney cancer	0.000206	0.00178	CcSEcCtD
Acetazolamide—Discomfort—Gemcitabine—kidney cancer	0.000206	0.00178	CcSEcCtD
Acetazolamide—Urticaria—Sorafenib—kidney cancer	0.000206	0.00177	CcSEcCtD
Acetazolamide—Haematuria—Capecitabine—kidney cancer	0.000206	0.00177	CcSEcCtD
Acetazolamide—Photosensitivity—Doxorubicin—kidney cancer	0.000205	0.00177	CcSEcCtD
Acetazolamide—Decreased appetite—Dactinomycin—kidney cancer	0.000205	0.00177	CcSEcCtD
Acetazolamide—Diarrhoea—Vinblastine—kidney cancer	0.000205	0.00177	CcSEcCtD
Acetazolamide—Body temperature increased—Sorafenib—kidney cancer	0.000205	0.00176	CcSEcCtD
Acetazolamide—Diarrhoea—Everolimus—kidney cancer	0.000204	0.00176	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Capecitabine—kidney cancer	0.000204	0.00176	CcSEcCtD
Acetazolamide—Fatigue—Dactinomycin—kidney cancer	0.000204	0.00175	CcSEcCtD
Acetazolamide—Agranulocytosis—Capecitabine—kidney cancer	0.000201	0.00173	CcSEcCtD
Acetazolamide—Dysgeusia—Paclitaxel—kidney cancer	0.000201	0.00173	CcSEcCtD
Acetazolamide—Hepatic failure—Doxorubicin—kidney cancer	0.000201	0.00173	CcSEcCtD
Acetazolamide—Anaphylactic shock—Gemcitabine—kidney cancer	0.0002	0.00172	CcSEcCtD
Acetazolamide—Dizziness—Vinblastine—kidney cancer	0.000198	0.00171	CcSEcCtD
Acetazolamide—Dizziness—Everolimus—kidney cancer	0.000198	0.0017	CcSEcCtD
Acetazolamide—Body temperature increased—Sunitinib—kidney cancer	0.000197	0.0017	CcSEcCtD
Acetazolamide—Diarrhoea—Erlotinib—kidney cancer	0.000197	0.0017	CcSEcCtD
Acetazolamide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000196	0.00169	CcSEcCtD
Acetazolamide—Feeling abnormal—Dactinomycin—kidney cancer	0.000195	0.00168	CcSEcCtD
Acetazolamide—Hypoaesthesia—Capecitabine—kidney cancer	0.000193	0.00166	CcSEcCtD
Acetazolamide—Vomiting—Vinblastine—kidney cancer	0.000191	0.00164	CcSEcCtD
Acetazolamide—Dizziness—Erlotinib—kidney cancer	0.000191	0.00164	CcSEcCtD
Acetazolamide—Ill-defined disorder—Paclitaxel—kidney cancer	0.000191	0.00164	CcSEcCtD
Acetazolamide—Vomiting—Everolimus—kidney cancer	0.00019	0.00163	CcSEcCtD
Acetazolamide—Paraesthesia—Vincristine—kidney cancer	0.000189	0.00163	CcSEcCtD
Acetazolamide—Agitation—Paclitaxel—kidney cancer	0.000189	0.00162	CcSEcCtD
Acetazolamide—Headache—Vinblastine—kidney cancer	0.000188	0.00162	CcSEcCtD
Acetazolamide—Headache—Everolimus—kidney cancer	0.000187	0.00161	CcSEcCtD
Acetazolamide—Body temperature increased—Dactinomycin—kidney cancer	0.000187	0.00161	CcSEcCtD
Acetazolamide—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000186	0.0016	CcSEcCtD
Acetazolamide—Asthenia—Sorafenib—kidney cancer	0.000186	0.0016	CcSEcCtD
Acetazolamide—Malaise—Paclitaxel—kidney cancer	0.000185	0.00159	CcSEcCtD
Acetazolamide—Hypoglycaemia—Doxorubicin—kidney cancer	0.000185	0.00159	CcSEcCtD
Acetazolamide—Leukopenia—Paclitaxel—kidney cancer	0.000184	0.00158	CcSEcCtD
Acetazolamide—Decreased appetite—Vincristine—kidney cancer	0.000183	0.00158	CcSEcCtD
Acetazolamide—Vomiting—Erlotinib—kidney cancer	0.000183	0.00158	CcSEcCtD
Acetazolamide—Erythema multiforme—Capecitabine—kidney cancer	0.000183	0.00158	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000182	0.00157	CcSEcCtD
Acetazolamide—Fatigue—Vincristine—kidney cancer	0.000182	0.00157	CcSEcCtD
Acetazolamide—Hyponatraemia—Doxorubicin—kidney cancer	0.000181	0.00156	CcSEcCtD
Acetazolamide—Headache—Erlotinib—kidney cancer	0.000181	0.00155	CcSEcCtD
Acetazolamide—Tinnitus—Capecitabine—kidney cancer	0.00018	0.00155	CcSEcCtD
Acetazolamide—Paraesthesia—Gemcitabine—kidney cancer	0.00018	0.00155	CcSEcCtD
Acetazolamide—Flushing—Capecitabine—kidney cancer	0.00018	0.00155	CcSEcCtD
Acetazolamide—Asthenia—Sunitinib—kidney cancer	0.000179	0.00154	CcSEcCtD
Acetazolamide—Nausea—Vinblastine—kidney cancer	0.000178	0.00153	CcSEcCtD
Acetazolamide—Somnolence—Gemcitabine—kidney cancer	0.000178	0.00153	CcSEcCtD
Acetazolamide—Convulsion—Paclitaxel—kidney cancer	0.000178	0.00153	CcSEcCtD
Acetazolamide—Nausea—Everolimus—kidney cancer	0.000177	0.00153	CcSEcCtD
Acetazolamide—Diarrhoea—Sorafenib—kidney cancer	0.000177	0.00153	CcSEcCtD
Acetazolamide—Decreased appetite—Gemcitabine—kidney cancer	0.000174	0.0015	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000173	0.00149	CcSEcCtD
Acetazolamide—Discomfort—Paclitaxel—kidney cancer	0.000173	0.00149	CcSEcCtD
Acetazolamide—Fatigue—Gemcitabine—kidney cancer	0.000173	0.00149	CcSEcCtD
Acetazolamide—Dizziness—Sorafenib—kidney cancer	0.000171	0.00148	CcSEcCtD
Acetazolamide—Nausea—Erlotinib—kidney cancer	0.000171	0.00147	CcSEcCtD
Acetazolamide—Diarrhoea—Sunitinib—kidney cancer	0.000171	0.00147	CcSEcCtD
Acetazolamide—Ataxia—Doxorubicin—kidney cancer	0.00017	0.00146	CcSEcCtD
Acetazolamide—Asthenia—Dactinomycin—kidney cancer	0.000169	0.00146	CcSEcCtD
Acetazolamide—Confusional state—Paclitaxel—kidney cancer	0.000169	0.00145	CcSEcCtD
Acetazolamide—Anaphylactic shock—Paclitaxel—kidney cancer	0.000168	0.00144	CcSEcCtD
Acetazolamide—Body temperature increased—Vincristine—kidney cancer	0.000167	0.00144	CcSEcCtD
Acetazolamide—Dysgeusia—Capecitabine—kidney cancer	0.000165	0.00142	CcSEcCtD
Acetazolamide—Dizziness—Sunitinib—kidney cancer	0.000165	0.00142	CcSEcCtD
Acetazolamide—Feeling abnormal—Gemcitabine—kidney cancer	0.000165	0.00142	CcSEcCtD
Acetazolamide—Shock—Paclitaxel—kidney cancer	0.000165	0.00142	CcSEcCtD
Acetazolamide—Vomiting—Sorafenib—kidney cancer	0.000165	0.00142	CcSEcCtD
Acetazolamide—Hypokalaemia—Doxorubicin—kidney cancer	0.000164	0.00141	CcSEcCtD
Acetazolamide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000164	0.00141	CcSEcCtD
Acetazolamide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000162	0.0014	CcSEcCtD
Acetazolamide—Headache—Sorafenib—kidney cancer	0.000162	0.0014	CcSEcCtD
Acetazolamide—Diarrhoea—Dactinomycin—kidney cancer	0.000162	0.00139	CcSEcCtD
Acetazolamide—Vomiting—Sunitinib—kidney cancer	0.000159	0.00137	CcSEcCtD
Acetazolamide—Body temperature increased—Gemcitabine—kidney cancer	0.000158	0.00136	CcSEcCtD
Acetazolamide—Ill-defined disorder—Capecitabine—kidney cancer	0.000156	0.00135	CcSEcCtD
Acetazolamide—Headache—Sunitinib—kidney cancer	0.000156	0.00135	CcSEcCtD
Acetazolamide—Nausea—Sorafenib—kidney cancer	0.000154	0.00133	CcSEcCtD
Acetazolamide—Malaise—Capecitabine—kidney cancer	0.000152	0.00131	CcSEcCtD
Acetazolamide—Asthenia—Vincristine—kidney cancer	0.000151	0.0013	CcSEcCtD
Acetazolamide—Leukopenia—Capecitabine—kidney cancer	0.000151	0.0013	CcSEcCtD
Acetazolamide—Paraesthesia—Paclitaxel—kidney cancer	0.00015	0.0013	CcSEcCtD
Acetazolamide—Vomiting—Dactinomycin—kidney cancer	0.00015	0.00129	CcSEcCtD
Acetazolamide—Somnolence—Paclitaxel—kidney cancer	0.000149	0.00128	CcSEcCtD
Acetazolamide—Nausea—Sunitinib—kidney cancer	0.000148	0.00128	CcSEcCtD
Acetazolamide—Dyspepsia—Paclitaxel—kidney cancer	0.000148	0.00127	CcSEcCtD
Acetazolamide—Decreased appetite—Paclitaxel—kidney cancer	0.000146	0.00125	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000145	0.00125	CcSEcCtD
Acetazolamide—Fatigue—Paclitaxel—kidney cancer	0.000144	0.00124	CcSEcCtD
Acetazolamide—Diarrhoea—Vincristine—kidney cancer	0.000144	0.00124	CcSEcCtD
Acetazolamide—Asthenia—Gemcitabine—kidney cancer	0.000144	0.00124	CcSEcCtD
Acetazolamide—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000142	0.00123	CcSEcCtD
Acetazolamide—Discomfort—Capecitabine—kidney cancer	0.000142	0.00122	CcSEcCtD
Acetazolamide—Nausea—Dactinomycin—kidney cancer	0.00014	0.00121	CcSEcCtD
Acetazolamide—Dizziness—Vincristine—kidney cancer	0.00014	0.0012	CcSEcCtD
Acetazolamide—Drowsiness—Doxorubicin—kidney cancer	0.000139	0.0012	CcSEcCtD
Acetazolamide—Confusional state—Capecitabine—kidney cancer	0.000139	0.00119	CcSEcCtD
Acetazolamide—Feeling abnormal—Paclitaxel—kidney cancer	0.000138	0.00119	CcSEcCtD
Acetazolamide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.000138	0.00119	CcSEcCtD
Acetazolamide—Diarrhoea—Gemcitabine—kidney cancer	0.000137	0.00118	CcSEcCtD
Acetazolamide—Shock—Capecitabine—kidney cancer	0.000135	0.00116	CcSEcCtD
Acetazolamide—Thrombocytopenia—Capecitabine—kidney cancer	0.000135	0.00116	CcSEcCtD
Acetazolamide—Vomiting—Vincristine—kidney cancer	0.000134	0.00116	CcSEcCtD
Acetazolamide—Urticaria—Paclitaxel—kidney cancer	0.000133	0.00115	CcSEcCtD
Acetazolamide—Haematuria—Doxorubicin—kidney cancer	0.000133	0.00114	CcSEcCtD
Acetazolamide—Body temperature increased—Paclitaxel—kidney cancer	0.000132	0.00114	CcSEcCtD
Acetazolamide—Headache—Vincristine—kidney cancer	0.000132	0.00114	CcSEcCtD
Acetazolamide—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000131	0.00113	CcSEcCtD
Acetazolamide—Agranulocytosis—Doxorubicin—kidney cancer	0.00013	0.00112	CcSEcCtD
Acetazolamide—Vomiting—Gemcitabine—kidney cancer	0.000127	0.0011	CcSEcCtD
Acetazolamide—Headache—Gemcitabine—kidney cancer	0.000125	0.00108	CcSEcCtD
Acetazolamide—Nausea—Vincristine—kidney cancer	0.000125	0.00108	CcSEcCtD
Acetazolamide—Hypoaesthesia—Doxorubicin—kidney cancer	0.000124	0.00107	CcSEcCtD
Acetazolamide—Paraesthesia—Capecitabine—kidney cancer	0.000124	0.00106	CcSEcCtD
Acetazolamide—Dyspepsia—Capecitabine—kidney cancer	0.000121	0.00104	CcSEcCtD
Acetazolamide—Asthenia—Paclitaxel—kidney cancer	0.00012	0.00104	CcSEcCtD
Acetazolamide—Decreased appetite—Capecitabine—kidney cancer	0.00012	0.00103	CcSEcCtD
Acetazolamide—Nausea—Gemcitabine—kidney cancer	0.000119	0.00102	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000119	0.00102	CcSEcCtD
Acetazolamide—Fatigue—Capecitabine—kidney cancer	0.000119	0.00102	CcSEcCtD
Acetazolamide—Erythema multiforme—Doxorubicin—kidney cancer	0.000118	0.00102	CcSEcCtD
Acetazolamide—Tinnitus—Doxorubicin—kidney cancer	0.000116	0.001	CcSEcCtD
Acetazolamide—Flushing—Doxorubicin—kidney cancer	0.000116	0.000997	CcSEcCtD
Acetazolamide—Diarrhoea—Paclitaxel—kidney cancer	0.000115	0.000987	CcSEcCtD
Acetazolamide—Feeling abnormal—Capecitabine—kidney cancer	0.000113	0.000976	CcSEcCtD
Acetazolamide—Dizziness—Paclitaxel—kidney cancer	0.000111	0.000954	CcSEcCtD
Acetazolamide—Urticaria—Capecitabine—kidney cancer	0.000109	0.000941	CcSEcCtD
Acetazolamide—Body temperature increased—Capecitabine—kidney cancer	0.000109	0.000936	CcSEcCtD
Acetazolamide—Vomiting—Paclitaxel—kidney cancer	0.000107	0.000917	CcSEcCtD
Acetazolamide—Dysgeusia—Doxorubicin—kidney cancer	0.000106	0.000916	CcSEcCtD
Acetazolamide—Headache—Paclitaxel—kidney cancer	0.000105	0.000904	CcSEcCtD
Acetazolamide—Ill-defined disorder—Doxorubicin—kidney cancer	0.000101	0.000868	CcSEcCtD
Acetazolamide—Agitation—Doxorubicin—kidney cancer	9.98e-05	0.000859	CcSEcCtD
Acetazolamide—Nausea—Paclitaxel—kidney cancer	9.96e-05	0.000857	CcSEcCtD
Acetazolamide—Asthenia—Capecitabine—kidney cancer	9.87e-05	0.00085	CcSEcCtD
Acetazolamide—Malaise—Doxorubicin—kidney cancer	9.8e-05	0.000843	CcSEcCtD
Acetazolamide—Leukopenia—Doxorubicin—kidney cancer	9.72e-05	0.000837	CcSEcCtD
Acetazolamide—Convulsion—Doxorubicin—kidney cancer	9.41e-05	0.00081	CcSEcCtD
Acetazolamide—Diarrhoea—Capecitabine—kidney cancer	9.41e-05	0.00081	CcSEcCtD
Acetazolamide—Discomfort—Doxorubicin—kidney cancer	9.14e-05	0.000787	CcSEcCtD
Acetazolamide—Dizziness—Capecitabine—kidney cancer	9.09e-05	0.000783	CcSEcCtD
Acetazolamide—Confusional state—Doxorubicin—kidney cancer	8.94e-05	0.00077	CcSEcCtD
Acetazolamide—Anaphylactic shock—Doxorubicin—kidney cancer	8.87e-05	0.000763	CcSEcCtD
Acetazolamide—Vomiting—Capecitabine—kidney cancer	8.74e-05	0.000753	CcSEcCtD
Acetazolamide—Shock—Doxorubicin—kidney cancer	8.72e-05	0.000751	CcSEcCtD
Acetazolamide—Thrombocytopenia—Doxorubicin—kidney cancer	8.68e-05	0.000747	CcSEcCtD
Acetazolamide—Headache—Capecitabine—kidney cancer	8.62e-05	0.000742	CcSEcCtD
Acetazolamide—Nausea—Capecitabine—kidney cancer	8.17e-05	0.000703	CcSEcCtD
Acetazolamide—Paraesthesia—Doxorubicin—kidney cancer	7.96e-05	0.000685	CcSEcCtD
Acetazolamide—Somnolence—Doxorubicin—kidney cancer	7.88e-05	0.000679	CcSEcCtD
Acetazolamide—Dyspepsia—Doxorubicin—kidney cancer	7.8e-05	0.000672	CcSEcCtD
Acetazolamide—Decreased appetite—Doxorubicin—kidney cancer	7.71e-05	0.000663	CcSEcCtD
Acetazolamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	7.65e-05	0.000659	CcSEcCtD
Acetazolamide—Fatigue—Doxorubicin—kidney cancer	7.64e-05	0.000658	CcSEcCtD
Acetazolamide—Feeling abnormal—Doxorubicin—kidney cancer	7.31e-05	0.000629	CcSEcCtD
Acetazolamide—Urticaria—Doxorubicin—kidney cancer	7.04e-05	0.000606	CcSEcCtD
Acetazolamide—Body temperature increased—Doxorubicin—kidney cancer	7.01e-05	0.000603	CcSEcCtD
Acetazolamide—Asthenia—Doxorubicin—kidney cancer	6.36e-05	0.000548	CcSEcCtD
Acetazolamide—Diarrhoea—Doxorubicin—kidney cancer	6.07e-05	0.000522	CcSEcCtD
Acetazolamide—Dizziness—Doxorubicin—kidney cancer	5.86e-05	0.000505	CcSEcCtD
Acetazolamide—Vomiting—Doxorubicin—kidney cancer	5.64e-05	0.000485	CcSEcCtD
Acetazolamide—Headache—Doxorubicin—kidney cancer	5.55e-05	0.000478	CcSEcCtD
Acetazolamide—Nausea—Doxorubicin—kidney cancer	5.27e-05	0.000453	CcSEcCtD
Acetazolamide—CA3—Metabolism—GSTM1—kidney cancer	4.33e-05	0.000351	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ACHE—kidney cancer	4.27e-05	0.000346	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTT1—kidney cancer	4.27e-05	0.000346	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTT1—kidney cancer	4.27e-05	0.000346	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ACHE—kidney cancer	4.27e-05	0.000346	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALAD—kidney cancer	4.25e-05	0.000344	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SCARB1—kidney cancer	4.15e-05	0.000337	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ST3GAL2—kidney cancer	4.14e-05	0.000336	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	4.13e-05	0.000335	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS1—kidney cancer	4.11e-05	0.000333	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—CYP1A1—kidney cancer	4.11e-05	0.000333	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CA9—kidney cancer	4.09e-05	0.000331	CbGpPWpGaD
Acetazolamide—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	4.06e-05	0.00033	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ITPR2—kidney cancer	4.05e-05	0.000329	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ALDH1A1—kidney cancer	4.05e-05	0.000329	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SCARB1—kidney cancer	4.04e-05	0.000328	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SCARB1—kidney cancer	4.04e-05	0.000328	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PSMD7—kidney cancer	4.03e-05	0.000327	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS1—kidney cancer	4e-05	0.000325	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS1—kidney cancer	4e-05	0.000325	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	3.99e-05	0.000323	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTT1—kidney cancer	3.99e-05	0.000323	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTT1—kidney cancer	3.99e-05	0.000323	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ACHE—kidney cancer	3.99e-05	0.000323	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ACHE—kidney cancer	3.99e-05	0.000323	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PSMD7—kidney cancer	3.92e-05	0.000318	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PSMD7—kidney cancer	3.92e-05	0.000318	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CA9—kidney cancer	3.92e-05	0.000318	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PGK1—kidney cancer	3.88e-05	0.000315	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC5A3—kidney cancer	3.88e-05	0.000315	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—BCHE—kidney cancer	3.82e-05	0.00031	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—LDHB—kidney cancer	3.81e-05	0.000309	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN2A—kidney cancer	3.79e-05	0.000308	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SCARB1—kidney cancer	3.77e-05	0.000306	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SCARB1—kidney cancer	3.77e-05	0.000306	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SLC5A5—kidney cancer	3.77e-05	0.000306	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CA9—kidney cancer	3.76e-05	0.000305	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS1—kidney cancer	3.74e-05	0.000303	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS1—kidney cancer	3.74e-05	0.000303	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—BCHE—kidney cancer	3.72e-05	0.000302	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—BCHE—kidney cancer	3.72e-05	0.000302	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTT1—kidney cancer	3.69e-05	0.0003	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ACHE—kidney cancer	3.69e-05	0.0003	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SLC5A5—kidney cancer	3.68e-05	0.000298	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SLC5A5—kidney cancer	3.68e-05	0.000298	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PSMD7—kidney cancer	3.66e-05	0.000297	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PSMD7—kidney cancer	3.66e-05	0.000297	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—RELA—kidney cancer	3.65e-05	0.000296	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—SLC2A1—kidney cancer	3.64e-05	0.000295	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MTOR—kidney cancer	3.58e-05	0.00029	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—SLC2A1—kidney cancer	3.55e-05	0.000288	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—SLC2A1—kidney cancer	3.55e-05	0.000288	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—POMC—kidney cancer	3.53e-05	0.000286	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SCARB1—kidney cancer	3.5e-05	0.000284	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CRABP1—kidney cancer	3.47e-05	0.000282	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—BCHE—kidney cancer	3.47e-05	0.000282	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—BCHE—kidney cancer	3.47e-05	0.000282	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS1—kidney cancer	3.46e-05	0.000281	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SLC5A5—kidney cancer	3.43e-05	0.000278	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SLC5A5—kidney cancer	3.43e-05	0.000278	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PSMD7—kidney cancer	3.39e-05	0.000275	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—CDKN1B—kidney cancer	3.36e-05	0.000273	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CRABP1—kidney cancer	3.33e-05	0.00027	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—SLC2A1—kidney cancer	3.31e-05	0.000269	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—SLC2A1—kidney cancer	3.31e-05	0.000269	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.29e-05	0.000267	CbGpPWpGaD
Acetazolamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.24e-05	0.000263	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ITPR2—kidney cancer	3.23e-05	0.000262	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—BCHE—kidney cancer	3.22e-05	0.000261	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—JUN—kidney cancer	3.2e-05	0.000259	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CRABP1—kidney cancer	3.19e-05	0.000259	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SLC5A5—kidney cancer	3.18e-05	0.000258	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ITPR2—kidney cancer	3.1e-05	0.000251	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—SLC2A1—kidney cancer	3.07e-05	0.000249	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—POMC—kidney cancer	3.06e-05	0.000248	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTP1—kidney cancer	3.04e-05	0.000246	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ITPR2—kidney cancer	2.97e-05	0.000241	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTP1—kidney cancer	2.96e-05	0.00024	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTP1—kidney cancer	2.96e-05	0.00024	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ACHE—kidney cancer	2.95e-05	0.000239	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTT1—kidney cancer	2.95e-05	0.000239	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—ABCB1—kidney cancer	2.88e-05	0.000233	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTT1—kidney cancer	2.82e-05	0.000229	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ACHE—kidney cancer	2.82e-05	0.000229	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTGS2—kidney cancer	2.82e-05	0.000228	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CRABP1—kidney cancer	2.81e-05	0.000228	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—ABCB1—kidney cancer	2.8e-05	0.000227	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—ABCB1—kidney cancer	2.8e-05	0.000227	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—VEGFA—kidney cancer	2.79e-05	0.000227	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—GSTM1—kidney cancer	2.79e-05	0.000226	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SCARB1—kidney cancer	2.79e-05	0.000226	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTP1—kidney cancer	2.76e-05	0.000224	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTP1—kidney cancer	2.76e-05	0.000224	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS1—kidney cancer	2.76e-05	0.000224	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—GSTM1—kidney cancer	2.72e-05	0.000221	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—GSTM1—kidney cancer	2.72e-05	0.000221	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTT1—kidney cancer	2.71e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ACHE—kidney cancer	2.71e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PSMD7—kidney cancer	2.71e-05	0.00022	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SCARB1—kidney cancer	2.67e-05	0.000217	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	2.66e-05	0.000216	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS1—kidney cancer	2.65e-05	0.000215	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—CYP1A1—kidney cancer	2.65e-05	0.000215	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MAPK3—kidney cancer	2.64e-05	0.000214	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	2.62e-05	0.000213	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—ABCB1—kidney cancer	2.62e-05	0.000212	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—ABCB1—kidney cancer	2.62e-05	0.000212	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ITPR2—kidney cancer	2.61e-05	0.000212	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PSMD7—kidney cancer	2.6e-05	0.000211	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—CYP1A1—kidney cancer	2.58e-05	0.000209	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—CYP1A1—kidney cancer	2.58e-05	0.000209	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—BCHE—kidney cancer	2.57e-05	0.000208	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SCARB1—kidney cancer	2.56e-05	0.000208	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTP1—kidney cancer	2.56e-05	0.000208	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—GSTM1—kidney cancer	2.54e-05	0.000206	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—GSTM1—kidney cancer	2.54e-05	0.000206	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS1—kidney cancer	2.54e-05	0.000206	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SLC5A5—kidney cancer	2.53e-05	0.000206	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.53e-05	0.000206	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—MAPK1—kidney cancer	2.52e-05	0.000204	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PSMD7—kidney cancer	2.49e-05	0.000202	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—BCHE—kidney cancer	2.46e-05	0.0002	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PTEN—kidney cancer	2.46e-05	0.000199	CbGpPWpGaD
Acetazolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.45e-05	0.000199	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—SLC2A1—kidney cancer	2.45e-05	0.000199	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTGS2—kidney cancer	2.44e-05	0.000198	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SLC5A5—kidney cancer	2.43e-05	0.000197	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—ABCB1—kidney cancer	2.42e-05	0.000197	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—CYP1A1—kidney cancer	2.41e-05	0.000195	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—CYP1A1—kidney cancer	2.41e-05	0.000195	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTT1—kidney cancer	2.38e-05	0.000193	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ACHE—kidney cancer	2.38e-05	0.000193	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—BCHE—kidney cancer	2.36e-05	0.000191	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—GSTM1—kidney cancer	2.35e-05	0.000191	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—SLC2A1—kidney cancer	2.35e-05	0.00019	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.34e-05	0.00019	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SLC5A5—kidney cancer	2.33e-05	0.000189	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SCARB1—kidney cancer	2.25e-05	0.000183	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—SLC2A1—kidney cancer	2.25e-05	0.000183	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS1—kidney cancer	2.23e-05	0.000181	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—CYP1A1—kidney cancer	2.23e-05	0.000181	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.2e-05	0.000178	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PSMD7—kidney cancer	2.19e-05	0.000177	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PTEN—kidney cancer	2.13e-05	0.000173	CbGpPWpGaD
Acetazolamide—CA9—Cellular responses to stress—TP53—kidney cancer	2.11e-05	0.000171	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—BCHE—kidney cancer	2.07e-05	0.000168	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC5A5—kidney cancer	2.05e-05	0.000166	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTP1—kidney cancer	2.04e-05	0.000166	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	2e-05	0.000162	CbGpPWpGaD
Acetazolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.99e-05	0.000161	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—SLC2A1—kidney cancer	1.98e-05	0.00016	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—POMC—kidney cancer	1.97e-05	0.00016	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTP1—kidney cancer	1.96e-05	0.000159	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—ABCB1—kidney cancer	1.93e-05	0.000157	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—POMC—kidney cancer	1.92e-05	0.000156	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—POMC—kidney cancer	1.92e-05	0.000156	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTP1—kidney cancer	1.88e-05	0.000152	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—GSTM1—kidney cancer	1.88e-05	0.000152	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—ABCB1—kidney cancer	1.85e-05	0.00015	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—GSTM1—kidney cancer	1.8e-05	0.000146	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—POMC—kidney cancer	1.8e-05	0.000146	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—POMC—kidney cancer	1.8e-05	0.000146	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—CYP1A1—kidney cancer	1.78e-05	0.000144	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—ABCB1—kidney cancer	1.78e-05	0.000144	CbGpPWpGaD
Acetazolamide—AQP1—Metabolism—PIK3CA—kidney cancer	1.73e-05	0.000141	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—GSTM1—kidney cancer	1.72e-05	0.00014	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—CYP1A1—kidney cancer	1.71e-05	0.000138	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—POMC—kidney cancer	1.66e-05	0.000135	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTP1—kidney cancer	1.65e-05	0.000134	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—CYP1A1—kidney cancer	1.63e-05	0.000133	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.62e-05	0.000132	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.6e-05	0.00013	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTGS2—kidney cancer	1.57e-05	0.000128	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—ABCB1—kidney cancer	1.56e-05	0.000127	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTGS2—kidney cancer	1.53e-05	0.000124	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTGS2—kidney cancer	1.53e-05	0.000124	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—GSTM1—kidney cancer	1.52e-05	0.000123	CbGpPWpGaD
Acetazolamide—CA3—Metabolism—PIK3CA—kidney cancer	1.5e-05	0.000122	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.49e-05	0.000121	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.47e-05	0.000119	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—CYP1A1—kidney cancer	1.44e-05	0.000117	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTGS2—kidney cancer	1.43e-05	0.000116	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTGS2—kidney cancer	1.43e-05	0.000116	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.41e-05	0.000115	CbGpPWpGaD
Acetazolamide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.4e-05	0.000113	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PTEN—kidney cancer	1.37e-05	0.000111	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PTEN—kidney cancer	1.34e-05	0.000108	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PTEN—kidney cancer	1.34e-05	0.000108	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTGS2—kidney cancer	1.33e-05	0.000108	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—POMC—kidney cancer	1.33e-05	0.000108	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—POMC—kidney cancer	1.27e-05	0.000103	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PTEN—kidney cancer	1.25e-05	0.000101	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PTEN—kidney cancer	1.25e-05	0.000101	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ACY1—kidney cancer	1.24e-05	0.000101	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—POMC—kidney cancer	1.22e-05	9.89e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PTEN—kidney cancer	1.16e-05	9.38e-05	CbGpPWpGaD
Acetazolamide—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.13e-05	9.18e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—POMC—kidney cancer	1.07e-05	8.69e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PDHB—kidney cancer	1.06e-05	8.58e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTGS2—kidney cancer	1.06e-05	8.58e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Biological oxidations—POMC—kidney cancer	1.05e-05	8.56e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTGS2—kidney cancer	1.01e-05	8.23e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CCBL1—kidney cancer	9.95e-06	8.07e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTGS2—kidney cancer	9.72e-06	7.89e-05	CbGpPWpGaD
Acetazolamide—CA14—Metabolism—PIK3CA—kidney cancer	9.68e-06	7.85e-05	CbGpPWpGaD
Acetazolamide—CA5A—Metabolism—PIK3CA—kidney cancer	9.44e-06	7.65e-05	CbGpPWpGaD
Acetazolamide—CA6—Metabolism—PIK3CA—kidney cancer	9.44e-06	7.65e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PTEN—kidney cancer	9.23e-06	7.48e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PTEN—kidney cancer	8.84e-06	7.17e-05	CbGpPWpGaD
Acetazolamide—CA7—Metabolism—PIK3CA—kidney cancer	8.81e-06	7.15e-05	CbGpPWpGaD
Acetazolamide—CA5B—Metabolism—PIK3CA—kidney cancer	8.81e-06	7.15e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.63e-06	7e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PPAT—kidney cancer	8.63e-06	7e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTGS2—kidney cancer	8.55e-06	6.93e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PTEN—kidney cancer	8.48e-06	6.88e-05	CbGpPWpGaD
Acetazolamide—CA12—Metabolism—PIK3CA—kidney cancer	8.16e-06	6.62e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—APRT—kidney cancer	8.02e-06	6.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—FH—kidney cancer	8.02e-06	6.51e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GPC3—kidney cancer	7.54e-06	6.12e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PTEN—kidney cancer	7.45e-06	6.05e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CA2—kidney cancer	7.34e-06	5.95e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALAD—kidney cancer	7.15e-06	5.8e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	6.98e-06	5.66e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	6.82e-06	5.53e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.54e-06	5.3e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PGK1—kidney cancer	6.54e-06	5.3e-05	CbGpPWpGaD
Acetazolamide—CA4—Metabolism—PIK3CA—kidney cancer	6.51e-06	5.28e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—LDHB—kidney cancer	6.41e-06	5.2e-05	CbGpPWpGaD
Acetazolamide—CA2—Metabolism—PIK3CA—kidney cancer	6.24e-06	5.06e-05	CbGpPWpGaD
Acetazolamide—CA1—Metabolism—PIK3CA—kidney cancer	5.98e-06	4.85e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CA9—kidney cancer	5.56e-06	4.51e-05	CbGpPWpGaD
Acetazolamide—CA9—Metabolism—PIK3CA—kidney cancer	5.26e-06	4.27e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CRABP1—kidney cancer	4.73e-06	3.83e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ITPR2—kidney cancer	4.39e-06	3.56e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ACHE—kidney cancer	4.01e-06	3.25e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTT1—kidney cancer	4.01e-06	3.25e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SCARB1—kidney cancer	3.79e-06	3.08e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS1—kidney cancer	3.75e-06	3.05e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PSMD7—kidney cancer	3.68e-06	2.99e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—BCHE—kidney cancer	3.49e-06	2.83e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.45e-06	2.8e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.33e-06	2.7e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTP1—kidney cancer	2.78e-06	2.25e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—ABCB1—kidney cancer	2.63e-06	2.13e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—GSTM1—kidney cancer	2.55e-06	2.07e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.42e-06	1.96e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—POMC—kidney cancer	1.8e-06	1.46e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTGS2—kidney cancer	1.44e-06	1.17e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PTEN—kidney cancer	1.25e-06	1.02e-05	CbGpPWpGaD
Acetazolamide—CYP3A4—Metabolism—PIK3CA—kidney cancer	8.85e-07	7.18e-06	CbGpPWpGaD
